Alex_Toker

Alex Toker

Alex Toker

Add article description

Alex Toker is currently a professor at the Department of Pathology at Beth Israel Deaconess Medical Center, Harvard Medical School and Chief of the Division of Signal Transduction and Associate Director of the Cancer Research Institute in the Cancer Center.[1][2] Toker is an expert in the signaling mechanisms that govern cancer progression.[3] His research focus on understanding mechanism of cancer including tumor cell survival, invasion and metastasis. He is currently editor-in-chief of the Journal of Biological Chemistry.[4][5]

Quick Facts Prof. Alex Toker, Alma mater ...

In 2022 Toker was the recipient of the Avanti Award in Lipids.[6]

References

  1. [1]
    "Home". www.tokerlab.com. Retrieved August 7, 2021.
  2. [2]
    "Alex Toker | Harvard Catalyst Profiles | Harvard Catalyst". connects.catalyst.harvard.edu. Retrieved August 7, 2021.
  3. [3]
    "ASBMB names 2022 award winners". www.asbmb.org. Retrieved January 8, 2024.
  4. [4]
    "Journal of Biological Chemistry names new editor-in-chief". www.asbmb.org. Retrieved August 7, 2021.
  5. [5]
    "Journal of Biological Chemistry". www.jbc.org. Retrieved August 7, 2021.
  6. [6]
    "Avanti Awards in Lipids". Avanti Polar Lipids (en-US). Retrieved January 8, 2024.


Flag of United StatesScientist icon

This biographical article related to medicine in the United States is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article Alex_Toker, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.